Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
PDF) Free Kappa and Lambda Light Chains in Plasma Cell Dyscrasias
Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies
Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology and the Internat
Freelite® Human Kappa Free kit For use on the Roche Cobas Integra® For in vitro diagnostic use Product Code: LK016.RI
Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment
PDF) Quantitative Serum Free Light Chain Assay - Analytical Issues
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance - ScienceDirect
Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma | Leukemia
Freelite® & Hevylite®
Freelite® & Hevylite®
Cancers | Free Full-Text | Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)
PDF) Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney diesease on haemolysis
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
Freelite® & Hevylite®
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation | Haematologica
Serum free light chains in clinical laboratory diagnostics - ScienceDirect
Untitled
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
